200 related articles for article (PubMed ID: 17507208)
41. Major glucuronide metabolites of testosterone are primarily transported by MRP2 and MRP3 in human liver, intestine and kidney.
Li CY; Basit A; Gupta A; Gáborik Z; Kis E; Prasad B
J Steroid Biochem Mol Biol; 2019 Jul; 191():105350. PubMed ID: 30959153
[TBL] [Abstract][Full Text] [Related]
42. Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3.
Chu XY; Huskey SE; Braun MP; Sarkadi B; Evans DC; Evers R
J Pharmacol Exp Ther; 2004 Apr; 309(1):156-64. PubMed ID: 14722317
[TBL] [Abstract][Full Text] [Related]
43. Efflux excretion of bisdemethoxycurcumin-O-glucuronide in UGT1A1-overexpressing HeLa cells: Identification of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins 1 (MRP1) as the glucuronide transporters.
Yang J; Zhang B; Qin Z; Li S; Xu J; Yao Z; Zhang X; Gonzalez FJ; Yao X
Biofactors; 2018 Nov; 44(6):558-569. PubMed ID: 30334318
[TBL] [Abstract][Full Text] [Related]
44. Vectorial transport of fexofenadine across Caco-2 cells: involvement of apical uptake and basolateral efflux transporters.
Ming X; Knight BM; Thakker DR
Mol Pharm; 2011 Oct; 8(5):1677-86. PubMed ID: 21780830
[TBL] [Abstract][Full Text] [Related]
45. Cysteinyl Leukotriene Receptor 1/2 Antagonists Nonselectively Modulate Organic Anion Transport by Multidrug Resistance Proteins (MRP1-4).
Csandl MA; Conseil G; Cole SP
Drug Metab Dispos; 2016 Jun; 44(6):857-66. PubMed ID: 27068271
[TBL] [Abstract][Full Text] [Related]
46. Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2.
Pál A; Méhn D; Molnár E; Gedey S; Mészáros P; Nagy T; Glavinas H; Janáky T; von Richter O; Báthori G; Szente L; Krajcsi P
J Pharmacol Exp Ther; 2007 Jun; 321(3):1085-94. PubMed ID: 17347325
[TBL] [Abstract][Full Text] [Related]
47. Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Lin X; Skolnik S; Chen X; Wang J
Drug Metab Dispos; 2011 Feb; 39(2):265-74. PubMed ID: 21051535
[TBL] [Abstract][Full Text] [Related]
48. Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers.
Liang E; Proudfoot J; Yazdanian M
Pharm Res; 2000 Oct; 17(10):1168-74. PubMed ID: 11145220
[TBL] [Abstract][Full Text] [Related]
49. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
Dahan A; Sabit H; Amidon GL
Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
[TBL] [Abstract][Full Text] [Related]
50. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium.
Swed A; Eyal S; Madar I; Zohar-Kontante H; Weiss L; Hoffman A
Mol Pharm; 2009; 6(6):1883-90. PubMed ID: 19722701
[TBL] [Abstract][Full Text] [Related]
51. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP.
Xiao L; Yi T; Chen M; Lam CW; Zhou H
Eur J Pharm Sci; 2016 Oct; 93():456-67. PubMed ID: 27586020
[TBL] [Abstract][Full Text] [Related]
52. Role of intestinal first-pass metabolism of baicalein in its absorption process.
Zhang L; Lin G; Chang Q; Zuo Z
Pharm Res; 2005 Jul; 22(7):1050-8. PubMed ID: 16028005
[TBL] [Abstract][Full Text] [Related]
53. Metabolism of flavonoids via enteric recycling: mechanistic studies of disposition of apigenin in the Caco-2 cell culture model.
Hu M; Chen J; Lin H
J Pharmacol Exp Ther; 2003 Oct; 307(1):314-21. PubMed ID: 12893842
[TBL] [Abstract][Full Text] [Related]
54. Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions.
Bodo A; Bakos E; Szeri F; Varadi A; Sarkadi B
J Biol Chem; 2003 Jun; 278(26):23529-37. PubMed ID: 12704183
[TBL] [Abstract][Full Text] [Related]
55. Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers.
Brand W; van der Wel PA; Rein MJ; Barron D; Williamson G; van Bladeren PJ; Rietjens IM
Drug Metab Dispos; 2008 Sep; 36(9):1794-802. PubMed ID: 18515333
[TBL] [Abstract][Full Text] [Related]
56. Transport mechanisms for soy isoflavones and microbial metabolites dihydrogenistein and dihydrodaidzein across monolayers and membranes.
Kobayashi S; Shinohara M; Nagai T; Konishi Y
Biosci Biotechnol Biochem; 2013; 77(11):2210-7. PubMed ID: 24200780
[TBL] [Abstract][Full Text] [Related]
57. Efficiency of transcellular transport and efflux of flavonoids with different glycosidic units from flavonoids of Litsea coreana L. in a MDCK epithelial cell monolayer model.
Chen Z; Ma T; Huang C; Zhang L; Zhong J; Han J; Hu T; Li J
Eur J Pharm Sci; 2014 Mar; 53():69-76. PubMed ID: 24365259
[TBL] [Abstract][Full Text] [Related]
58. In vitro studies of intestinal permeability and hepatic and intestinal metabolism of 8-prenylnaringenin, a potent phytoestrogen from hops (Humulus lupulus L.).
Nikolic D; Li Y; Chadwick LR; van Breemen RB
Pharm Res; 2006 May; 23(5):864-72. PubMed ID: 16715376
[TBL] [Abstract][Full Text] [Related]
59. Human and rat ABC transporter efflux of bisphenol a and bisphenol a glucuronide: interspecies comparison and implications for pharmacokinetic assessment.
Mazur CS; Marchitti SA; Dimova M; Kenneke JF; Lumen A; Fisher J
Toxicol Sci; 2012 Aug; 128(2):317-25. PubMed ID: 22552776
[TBL] [Abstract][Full Text] [Related]
60. Site-specific bidirectional efflux of 2,4-dinitrophenyl-S-glutathione, a substrate of multidrug resistance-associated proteins, in rat intestine and Caco-2 cells.
Yokooji T; Murakami T; Yumoto R; Nagai J; Takano M
J Pharm Pharmacol; 2007 Apr; 59(4):513-20. PubMed ID: 17430634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]